APA Citation

Goldberg, S. B., & Herbst, R. S. (2018). Should chemotherapy plus immune checkpoint inhibition be the standard front-line therapy for metastatic NSCLC? Cancer.

Citação norma Chicago

Goldberg, Sarah B., and Roy S. Herbst. "Should Chemotherapy Plus Immune Checkpoint Inhibition Be the Standard Front-line Therapy for Metastatic NSCLC?" Cancer 2018.

MLA Citation

Goldberg, Sarah B., and Roy S. Herbst. "Should Chemotherapy Plus Immune Checkpoint Inhibition Be the Standard Front-line Therapy for Metastatic NSCLC?" Cancer 2018.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.